Treatment of prostate cancer – Endocrine therapies - specialist management - historical notes
Date | Note |
---|---|
27/02/2025 | Addition of Relugolix (SMC2678), ERFC Feb 25. |
06/02/2025 | Updated prescribing information gonadorelin analogues, ERWG Jan 2025 |
16/11/2023 | Revised simplified formulary recommendations, ERWG May 23. |